Coeptis Therapeutics Holdings (COEPW) Change in Account Payables (2022 - 2025)
Historic Change in Account Payables for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to -$241188.0.
- Coeptis Therapeutics Holdings' Change in Account Payables fell 6417.51% to -$241188.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$346606.0, marking a year-over-year decrease of 15314.1%. This contributed to the annual value of -$149935.0 for FY2024, which is 11135.29% down from last year.
- According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Change in Account Payables is -$241188.0, which was down 6417.51% from -$91832.0 recorded in Q2 2025.
- In the past 5 years, Coeptis Therapeutics Holdings' Change in Account Payables registered a high of $937694.0 during Q4 2023, and its lowest value of -$241188.0 during Q3 2025.
- In the last 4 years, Coeptis Therapeutics Holdings' Change in Account Payables had a median value of $23671.0 in 2022 and averaged $43569.6.
- As far as peak fluctuations go, Coeptis Therapeutics Holdings' Change in Account Payables surged by 54542.69% in 2023, and later plummeted by 26930.46% in 2024.
- Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Change in Account Payables stood at -$228851.0 in 2022, then surged by 509.74% to $937694.0 in 2023, then plummeted by 85.55% to $135521.0 in 2024, then crashed by 277.97% to -$241188.0 in 2025.
- Its Change in Account Payables was -$241188.0 in Q3 2025, compared to -$91832.0 in Q2 2025 and -$149107.0 in Q1 2025.